Terravia Holdings (NASDAQ: TVIA) is one of 46 public companies in the “Specialty Chemicals” industry, but how does it contrast to its competitors? We will compare Terravia Holdings to similar businesses based on the strength of its profitability, institutional ownership, dividends, risk, valuation, analyst recommendations and earnings.
Valuation and Earnings
This table compares Terravia Holdings and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Terravia Holdings Competitors||$2.01 billion||$127.25 million||237.81|
Terravia Holdings’ competitors have higher revenue and earnings than Terravia Holdings. Terravia Holdings is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This is a summary of recent recommendations for Terravia Holdings and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Terravia Holdings Competitors||164||996||1248||24||2.47|
Terravia Holdings currently has a consensus target price of $1.50, indicating a potential upside of 3,650.00%. As a group, “Specialty Chemicals” companies have a potential downside of 3.34%. Given Terravia Holdings’ higher probable upside, equities research analysts clearly believe Terravia Holdings is more favorable than its competitors.
This table compares Terravia Holdings and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Terravia Holdings Competitors||-6.88%||-0.16%||3.55%|
Insider & Institutional Ownership
43.4% of Terravia Holdings shares are owned by institutional investors. Comparatively, 66.5% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 10.1% of Terravia Holdings shares are owned by company insiders. Comparatively, 7.6% of shares of all “Specialty Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Volatility and Risk
Terravia Holdings has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Terravia Holdings’ competitors have a beta of 1.46, suggesting that their average share price is 46% more volatile than the S&P 500.
Terravia Holdings competitors beat Terravia Holdings on 8 of the 11 factors compared.
About Terravia Holdings
Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.
Receive News & Ratings for Terravia Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terravia Holdings and related companies with MarketBeat.com's FREE daily email newsletter.